Aventura Private Wealth’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.1K Sell
255
-5
-2% -$956 0.02% 331
2026
Q1
$47.7K Sell
260
-13
-5% -$2.4K 0.02% 328
2025
Q4
$48K Sell
273
-94
-26% -$15.4K 0.02% 298
2025
Q3
$51.4K Sell
367
-35
-9% -$4.73K 0.02% 289
2025
Q2
$50.5K Sell
402
-138
-26% -$17.2K 0.02% 280
2025
Q1
$73.9K Sell
540
-59
-10% -$8.43K 0.04% 219
2024
Q4
$91.6K Buy
+599
New +$101K 0.05% 197

Other funds holding BIIB

Aventura Private Wealth's BIIB Position: Q2 2026 in Review

Aventura Private Wealth reduced its Biogen (BIIB) stake by 1.9% in Q2 2026, selling an estimated $956 and leaving 255 shares worth $55.1K. The position accounts for 0.02% of the portfolio, ranked #331.

Aventura Private Wealth first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. The position peaked at $91.6K in Q4 2024. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Aventura Private Wealth held 255 shares of Biogen worth $55.1K as of Q2 2026.
  • Aventura Private Wealth sold 5 Biogen shares in Q2 2026, an estimated $956.
  • Biogen made up 0.02% of Aventura Private Wealth's portfolio in Q2 2026, its #331 holding.
  • Aventura Private Wealth first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • Aventura Private Wealth's Biogen position peaked at $91.6K in Q4 2024.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.